On Feb. 15, biopharmaceutical company Biogen Idec (NASDAQ:BIIB) released fourth-quarter earnings for the period ended Dec. 31.
- Net sales increased by 11.9%, primarily because of a 6% increase in sales of Avonex, while Rituxan revenues were up by 20%.
- The company expects total revenue to grow in the mid-teens over 2006, capital expenditures to be in the range of $250 million to $300 million, and earnings per share to be in the range of $1.69 to $1.84 for the full year 2007.
- Biogen Idec is a three-star stock (out of five) in CAPS, our community-based stock-rating service.
(Figures in millions, except per-share data)
Income Statement Highlights
| Q4 2006 | Q4 2005 | Change | |
|---|---|---|---|
| Sales | $708.3 | $632.9 | 11.9% | 
| Net Profit | $108.6 | $55.6 | 95.4% | 
| EPS | $0.32 | $0.16 | 100.0% | 
| Diluted Shares | 343.1 | 345.1 | (0.6%) | 
Get back to basics with a look at the income statement.
Margin Checkup
| Q4 2006 | Q4 2005 | Change* | |
|---|---|---|---|
| Gross Margin | 91.2% | 82.1% | 9.1 | 
| Operating Margin | 27.1% | 14.7% | 12.3 | 
| Net Margin | 15.3% | 8.8% | 6.6 | 
Margins are the earnings engine. See how they work.
Balance Sheet Highlights
| Assets | Q4 2006 | Q4 2005 | Change | 
|---|---|---|---|
| Cash + ST Invest. | $902.7 | $850.8 | 6.1% | 
| Accounts Rec. | $317.4 | $265.7 | 19.4% | 
| Inventory | $169.1 | $182.8 | (7.5%) | 
Data not available for liabilities.
Learn the ways of the balance sheet.
Cash Flow Highlights
A statement of cash flows was not provided. Boo!
Find out why Fools always follow the money.
Related Companies:
- Genentech (NYSE:DNA)
- Amgen (NASDAQ:AMGN)
- Elan (NYSE:ELN)
- Gilead Sciences (NASDAQ:GILD)
- Genzyme (NASDAQ:GENZ)
Related Foolishness:
Biogen Idec is a Stock Advisor recommendation. To find out why, and see which other companies made the cut, you can take a 30-day free trial of our flagship newsletter.
Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.

